233 related articles for article (PubMed ID: 9648070)
1. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.
Abe K; Miyazaki M; Koji T; Furusu A; Ozono Y; Harada T; Sakai H; Nakane PK; Kohno S
Kidney Int; 1998 Jul; 54(1):120-30. PubMed ID: 9648070
[TBL] [Abstract][Full Text] [Related]
2. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
[TBL] [Abstract][Full Text] [Related]
3. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization.
Miyazaki M; Abe K; Koji T; Furusu A; Ozono Y; Harada T; Nakane PK; Yagame M; Endoh M; Nomoto Y; Sakai H
J Am Soc Nephrol; 1996 Nov; 7(11):2428-33. PubMed ID: 8959636
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization.
Abe K; Miyazaki M; Koji T; Furusu A; Nakamura-Kurashige T; Nishino T; Ozono Y; Harada T; Sakai H; Kohno S
Kidney Int; 2001 Jul; 60(1):137-46. PubMed ID: 11422745
[TBL] [Abstract][Full Text] [Related]
5. Involvement of IL-4 in human glomerulonephritis: an in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA.
Furusu A; Miyazaki M; Koji T; Abe K; Ozono Y; Harada T; Nakane PK; Hara K; Kohno S
J Am Soc Nephrol; 1997 May; 8(5):730-41. PubMed ID: 9176842
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
[TBL] [Abstract][Full Text] [Related]
8. [PPAR-gamma expression in the kidney of actively proliferating glomerulonephritis].
Xiong Z; Huang H; Li J; Wang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 35(5):499-502. PubMed ID: 14601307
[TBL] [Abstract][Full Text] [Related]
9. Intraglomerular C3 synthesis in rats with passive Heymann nephritis.
Sasaki O; Zhou W; Miyazaki M; Abe K; Koji T; Verroust P; Tsukasaki S; Ozono Y; Harada T; Nakane PK; Kohno S; Sacks SH
Am J Pathol; 1997 Nov; 151(5):1249-56. PubMed ID: 9358750
[TBL] [Abstract][Full Text] [Related]
10. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
[TBL] [Abstract][Full Text] [Related]
12. Renal cortical complement C3 gene expression in IgA nephropathy.
Montinaro V; Gesualdo L; Ranieri E; Monno R; Grandaliano G; Schena FP
J Am Soc Nephrol; 1997 Mar; 8(3):415-25. PubMed ID: 9071710
[TBL] [Abstract][Full Text] [Related]
13. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.
Suzuki D; Miyata T; Nangaku M; Takano H; Saotome N; Toyoda M; Mori Y; Zhang SY; Inagi R; Endoh M; Kurokawa K; Sakai H
J Am Soc Nephrol; 1999 Dec; 10(12):2606-13. PubMed ID: 10589701
[TBL] [Abstract][Full Text] [Related]
14. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis.
Niemir ZI; Stein H; Ciechanowicz A; Olejniczak P; Dworacki G; Ritz E; Waldherr R; Czekalski S
Am J Kidney Dis; 2004 Jun; 43(6):983-98. PubMed ID: 15168378
[TBL] [Abstract][Full Text] [Related]
15. Histological reappraisal of IgA nephropathy: the role of glomerular pattern of injury and mesangial complement deposition.
Obrișcă B; Mocanu V; Jurubiță R; Vrabie A; Berechet A; Lujinschi Ș; Sorohan B; Andronesi A; Achim C; Lupușoru G; Micu G; Caceaune N; Gherghiceanu M; Ismail G
BMC Nephrol; 2024 Apr; 25(1):145. PubMed ID: 38658875
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a role for local complement expression in a murine model of progressive glomerulonephritis.
Welch TR; Frenzke M; Witte D
Pediatr Res; 2000 Aug; 48(2):200-5. PubMed ID: 10926295
[TBL] [Abstract][Full Text] [Related]
17. Localization of decay accelerating factor in normal and diseased kidneys.
Cosio FG; Sedmak DD; Mahan JD; Nahman NS
Kidney Int; 1989 Jul; 36(1):100-7. PubMed ID: 2478749
[TBL] [Abstract][Full Text] [Related]
18. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
19. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
Danilewicz M; Wagrowska-Danilewicz M
J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
[TBL] [Abstract][Full Text] [Related]
20. Expression of tenascin in mesangial injury in experimental glomerulonephritis.
Jyo Y; Sasaki T; Nomura S; Tamai H; Kawai S; Osawa G; Nakao N; Kusakabe M
Exp Nephrol; 1997; 5(5):423-8. PubMed ID: 9386979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
